Dear Colleague: I am writing to provide you with brief updates on COVID-19 and monkeypox. VDH Adopts CDC’s Revised COVID-19 Infection Prevention and Control Guidance On September 23, 2022, the Centers for Disease Control and Prevention (CDC) released updated COVID-19 infection prevention and control (IPC) recommendations for healthcare personnel (HCP). Corresponding guidance for isolation and work restriction of […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-10-07 15:11:292022-10-07 15:11:29COVID-19 and Monkeypox Updates for Virginia
Dear Colleague, The Virginia Department of Health (VDH) is reporting an increase in meningococcal disease activity in the eastern region of Virginia. Six cases of invasive meningococcal disease serogroup Y were reported between June and August, which exceeds the expected number of cases. Whole genome sequencing confirmed that the cases are genetically linked, and thereby […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-09-23 14:06:292022-09-23 14:06:29Meningococcal Outbreak in Eastern Region | Letter from Virginia State Health Commissioner
The Nominating Committee met on August 16, 2022 to consider all eligible candidates for the upcoming term of office. The committee recommends the following slate for consideration by the society membership. MSV Board of Directors Term 2022-2023/2024 Officers (Elected for 1-year term) President-Elect | Alice Coombs, MD Speaker | Alan Wynn, MD Vice Speaker | […]
Opioid use disorders (OUD) affect over 2.1 million people in the United States. Sentara, in partnership with Get Waivered is pleased to offer two free facilitated opportunities for this virtual evidence-based training: Wednesday, September 21, 2022 4:30 p.m. – 5:30 p.m. Saturday, September 24, 2022 10:00 a.m. – 11:00 a.m. Because the path to recovery […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-09-14 14:31:012023-01-13 16:25:40Get Waivered: A Free Evidence-Based Training to Treat Opioid Use Disorder
CHICAGO—With a report issued today detailing the horrific toll of the nation’s overdose and death epidemic, the American Medical Association (AMA) calls for an all-hands approach — policymakers, public health experts, educators, faith leaders, and employers – to help save lives. While physicians and other health care professionals have reduced opioid prescribing in every state—by nearly […]
September 13th, 2022 | 11 a.m. CT/12:00 noon ET Hosted by Sandra Fryhofer, MD, Chair, AMA Board of Trustees Register Now Guests: Adam Sherwat, MD, Deputy Director, Office of Infectious Disease at FDA’s Center for Drug Evaluation and Research Brett W. Petersen, MD, MPH, Deputy Chief, Poxvirus and Rabies Branch, CDC’s Division of High-Consequence Pathogens and […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-09-08 14:06:022022-09-08 14:06:02New Webinar: Tecovirimat (“TPOXX”) for Treatment of Monkeypox
These webinars will cover an overview of the current monkeypox situation, epidemiology of the virus, risk assessment/communication, infection prevention and control, testing, collaboration with public health officials, and medical countermeasure strategies, including an in depth overview of the JYNNOES vaccine and TPOXX therapeutic. There will also be an allotted time for questions. Note: both sessions […]
https://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.png00adminhttps://www.msv.org/wp-content/uploads/2021/11/msv-logo_340x156.pngadmin2022-09-06 21:11:382023-01-13 16:26:50VDH Webinar: What Healthcare Professionals need to know about Monkeypox
COVID-19 and Monkeypox Updates for Virginia
Dear Colleague: I am writing to provide you with brief updates on COVID-19 and monkeypox. VDH Adopts CDC’s Revised COVID-19 Infection Prevention and Control Guidance On September 23, 2022, the Centers for Disease Control and Prevention (CDC) released updated COVID-19 infection prevention and control (IPC) recommendations for healthcare personnel (HCP). Corresponding guidance for isolation and work restriction of […]
Meningococcal Outbreak in Eastern Region | Letter from Virginia State Health Commissioner
Dear Colleague, The Virginia Department of Health (VDH) is reporting an increase in meningococcal disease activity in the eastern region of Virginia. Six cases of invasive meningococcal disease serogroup Y were reported between June and August, which exceeds the expected number of cases. Whole genome sequencing confirmed that the cases are genetically linked, and thereby […]
2022 Nominating Committee Report
The Nominating Committee met on August 16, 2022 to consider all eligible candidates for the upcoming term of office. The committee recommends the following slate for consideration by the society membership. MSV Board of Directors Term 2022-2023/2024 Officers (Elected for 1-year term) President-Elect | Alice Coombs, MD Speaker | Alan Wynn, MD Vice Speaker | […]
Get Waivered: A Free Evidence-Based Training to Treat Opioid Use Disorder
Opioid use disorders (OUD) affect over 2.1 million people in the United States. Sentara, in partnership with Get Waivered is pleased to offer two free facilitated opportunities for this virtual evidence-based training: Wednesday, September 21, 2022 4:30 p.m. – 5:30 p.m. Saturday, September 24, 2022 10:00 a.m. – 11:00 a.m. Because the path to recovery […]
AMA Report: Disturbing Trends on Overdose Deaths Requires Specific Actions, All-Hands Approach
CHICAGO—With a report issued today detailing the horrific toll of the nation’s overdose and death epidemic, the American Medical Association (AMA) calls for an all-hands approach — policymakers, public health experts, educators, faith leaders, and employers – to help save lives. While physicians and other health care professionals have reduced opioid prescribing in every state—by nearly […]
New Webinar: Tecovirimat (“TPOXX”) for Treatment of Monkeypox
September 13th, 2022 | 11 a.m. CT/12:00 noon ET Hosted by Sandra Fryhofer, MD, Chair, AMA Board of Trustees Register Now Guests: Adam Sherwat, MD, Deputy Director, Office of Infectious Disease at FDA’s Center for Drug Evaluation and Research Brett W. Petersen, MD, MPH, Deputy Chief, Poxvirus and Rabies Branch, CDC’s Division of High-Consequence Pathogens and […]
VDH Webinar: What Healthcare Professionals need to know about Monkeypox
These webinars will cover an overview of the current monkeypox situation, epidemiology of the virus, risk assessment/communication, infection prevention and control, testing, collaboration with public health officials, and medical countermeasure strategies, including an in depth overview of the JYNNOES vaccine and TPOXX therapeutic. There will also be an allotted time for questions. Note: both sessions […]